Flare After Switching from Intravenous Tocilizumab to Subcutaneous Formulation in Patients with Rheumatoid Arthritis

被引：0
|
作者：
Ahn, Soo Min [1 ]
Oh, Ji Seon [2 ]
Heo, Hyun Mi [3 ]
Hong, Seokchan [3 ]
Lee, Chang-Keun [3 ]
Yoo, Bin [1 ]
Kim, Yong-Gil [3 ]
机构：
[1] ASAN Med Ctr, Seoul, South Korea
[2] Asan Med Ctr, Ulsan, South Korea
[3] Asan Med Ctr, Seoul, South Korea
来源：
ARTHRITIS & RHEUMATOLOGY | 2021年 / 73卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0836
引用
收藏
页码：1728 / 1730
页数：3
相关论文
共 50 条
  • [21] PATIENT-REPORTED OUTCOMES IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH SUBCUTANEOUS TOCILIZUMAB COMPARED WITH PLACEBO OR INTRAVENOUS TOCILIZUMAB IN COMBINATION WITH CSDMARDS
    Strand, V.
    Lampl, K.
    Birchwood, C.
    Pei, J.
    Tuckwell, K.
    Finch, R.
    Kivitz, A.
    Burmester, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 581 - 582
  • [22] EFFICACY AND SAFETY OF INTRAVENOUS AND SUBCUTANEOUS TOCILIZUMAB IN A COHORT OF PATIENTS AFFECTED BY RHEUMATOID ARTHRITIS IN REAL-LIFE
    Manfredi, L.
    Benfaremo, D.
    Tedesco, S.
    Danieli, M. G.
    Luchetti, M. M.
    Gabrielli, A.
    Pomponio, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1025 - 1026
  • [23] EFFICACY AND SAFETY OF INTRAVENOUS AND SUBCUTANEOUS TOCILIZUMAB IN A COHORT OF PATIENTS AFFECTED BY RHEUMATOID ARTHRITIS IN REAL-LIFE
    Pomponio, G.
    Tontini, C.
    Angeletti, A.
    Olivari, D.
    Benfaremo, D.
    Manfredi, L.
    Danieli, M. G.
    Fraticelli, P.
    Luchetti, M. M.
    Moroncini, G.
    Gabrielli, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1189 - 1189
  • [24] Similar Effectiveness of Both Formulations of Tocilizumab (TCZ) in Patients with Rheumatoid Arthritis (RA) Switching from Intravenous (IV) to Subcutaneous (SC) at 6 Months in Real Life
    Darloy, Jean
    Flipo, Rene-Marc
    Segaud, Nicolas
    Eschard, Jean-Paul
    Goeb, Vincent
    Salmon, Jean-Hugues
    Houvenagel, Eric
    Chopin, Clement
    Gally, Samuel
    Pau, David
    Idier, Isabelle
    Baudens, Guy
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [25] Phase III Study of the Efficacy and Safety of Subcutaneous Versus Intravenous Tocilizumab Monotherapy in Patients With Rheumatoid Arthritis
    Ogata, Atsushi
    Tanimura, Kazuhide
    Sugimoto, Toyohiko
    Inoue, Hiroshi
    Urata, Yukitomo
    Matsubara, Tsukasa
    Kondo, Masakazu
    Ueki, Yukitaka
    Iwahashi, Mitsuhiro
    Tohma, Shigeto
    Ohta, Shuji
    Saeki, Yukihiko
    Tanaka, Toshio
    ARTHRITIS CARE & RESEARCH, 2014, 66 (03) : 344 - 354
  • [26] ANALYSIS OF SPACING OF THE INTRAVENOUS ADMINISTRATION OF TOCILIZUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Ito, S.
    Kobayashi, D.
    Takai, C.
    Nemoto, T.
    Lee, H.
    Abe, A.
    Otani, H.
    Ishikawa, H.
    Murasawa, A.
    Narita, I.
    Nakazono, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1032 - 1032
  • [27] Potential patient benefit of a subcutaneous formulation of tocilizumab for the treatment of rheumatoid arthritis: a critical review
    Besada, Emilio
    PATIENT PREFERENCE AND ADHERENCE, 2014, 8 : 1051 - 1059
  • [28] Population Pharmacokinetics (PK) of Tocilizumab Following Intravenous (IV) and Subcutaneous (SC) Administration to Patients with Rheumatoid Arthritis (RA)
    Gibiansky, Leonid
    Frey, Nicolas
    Hsu, Joy C.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2014, 41 : S81 - S82
  • [29] INDUCTION AND PROGRESSION OF SUBCUTANEOUS NODULOSIS IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH TOCILIZUMAB
    Talotta, R.
    Batticciotto, A.
    Ditto, M. C.
    Gerardi, M. C.
    Ventura, D.
    Puttin, P. Sarzi
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1194 - 1194
  • [30] PREDICTORS OF DISEASE FLARE AFTER DISCONTINUATION OF CONCOMITANT METHOTREXATE IN JAPANESE PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH TOCILIZUMAB
    Asai, S.
    Takahashi, N.
    Kuwatsuka, Y.
    Ando, M.
    Ishiguro, N.
    Kojima, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 252 - 253
12345